Jardiance ® (empagliflozin) to be studied for the treatment of people with chronic heart failure

Jardiance ® (empagliflozin) to be studied for the treatment of people with chronic heart failure
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news